HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel NTRK1 Frameshift Mutation in Congenital Insensitivity to Pain With Anhidrosis.

Abstract
Congenital insensitivity to pain with anhidrosis is a rare autosomal recessive disorder. It has been reported that the defect in the NTRK1 gene encoding tropomyosin-related kinase A (TrkA) can cause congenital insensitivity to pain with anhidrosis. Nerve growth factor (NGF), the product of NGFB, mediates biological effects by binding to and activating tropomyosin-related kinase A. In addition, necdin (encoded by NDN) is also essential in nerve growth factor-tropomyosin-related kinase A pathway. We performed mutation analysis in NTRK1, NGFB, and NDN genes in a Chinese Han 17-year-old female patient with congenital insensitivity to pain with anhidrosis and her healthy family members. As a result, the patient was found to have a novel insertion in exon 7 (c.727insT) of NTRK1, which causes premature termination, and a single nucleotide polymorphism (rs2192206 G>A) in NDN. Our findings imply that the genetic variations of the nerve growth factor-tropomyosin-related kinase A pathway play an important role in congenital insensitivity to pain with anhidrosis.
AuthorsSen Liu, Nan Wu, Jiaqi Liu, Xuan Ming, Jun Chen, Derek Pavelec, Xinlin Su, Guixing Qiu, Ye Tian, Philip Giampietro, Zhihong Wu
JournalJournal of child neurology (J Child Neurol) Vol. 30 Issue 10 Pg. 1357-61 (Sep 2015) ISSN: 1708-8283 [Electronic] United States
PMID25316729 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2014.
Chemical References
  • Receptor, trkA
Topics
  • Adolescent
  • Asian People (genetics)
  • China
  • DNA Mutational Analysis
  • Female
  • Frameshift Mutation
  • Hereditary Sensory and Autonomic Neuropathies (genetics, pathology, physiopathology)
  • Humans
  • Pedigree
  • Receptor, trkA (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: